Jill D. Martin

Array ( [id] => 4105946 [patent_doc_number] => 06022736 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2000-02-08 [patent_title] => 'Nucleic acid vectors comprising DNase I hypersensitive sites' [patent_app_type] => 1 [patent_app_number] => 8/471483 [patent_app_country] => US [patent_app_date] => 1995-06-06 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 19 [patent_figures_cnt] => 21 [patent_no_of_words] => 19608 [patent_no_of_claims] => 33 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 87 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/022/06022736.pdf [firstpage_image] =>[orig_patent_app_number] => 471483 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4135765 [patent_doc_number] => 06015687 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2000-01-18 [patent_title] => 'Apoptosis-modulating proteins, DNA encoding the proteins and methods of use thereof' [patent_app_type] => 1 [patent_app_number] => 8/471057 [patent_app_country] => US [patent_app_date] => 1995-06-06 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 25 [patent_figures_cnt] => 11 [patent_no_of_words] => 14286 [patent_no_of_claims] => 1 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 105 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/015/06015687.pdf [firstpage_image] =>[orig_patent_app_number] => 471057 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3767456 [patent_doc_number] => 05773289 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1998-06-30 [patent_title] => 'AAV directed targeted integration' [patent_app_type] => 1 [patent_app_number] => 8/469552 [patent_app_country] => US [patent_app_date] => 1995-06-06 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 20 [patent_figures_cnt] => 62 [patent_no_of_words] => 14658 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 13 [patent_words_short_claim] => 29 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/773/05773289.pdf [firstpage_image] =>[orig_patent_app_number] => 469552 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4409566 [patent_doc_number] => 06310045 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2001-10-30 [patent_title] => 'Compositions and methods for cancer immunotherapy' [patent_app_type] => 1 [patent_app_number] => 8/474636 [patent_app_country] => US [patent_app_date] => 1995-06-06 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 22 [patent_figures_cnt] => 30 [patent_no_of_words] => 24881 [patent_no_of_claims] => 5 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 21 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/310/06310045.pdf [firstpage_image] =>[orig_patent_app_number] => 474636 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3818667 [patent_doc_number] => 05789651 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1998-08-04 [patent_title] => 'Isolation and characterization of Agouti: a diabetes/obesity related gene' [patent_app_type] => 1 [patent_app_number] => 8/465293 [patent_app_country] => US [patent_app_date] => 1995-06-05 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 9 [patent_figures_cnt] => 9 [patent_no_of_words] => 16546 [patent_no_of_claims] => 6 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 80 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/789/05789651.pdf [firstpage_image] =>[orig_patent_app_number] => 465293 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4159343 [patent_doc_number] => 06107541 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2000-08-22 [patent_title] => 'PRAD1 transgenic mice' [patent_app_type] => 1 [patent_app_number] => 8/460744 [patent_app_country] => US [patent_app_date] => 1995-06-02 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 18 [patent_figures_cnt] => 21 [patent_no_of_words] => 9819 [patent_no_of_claims] => 7 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 56 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/107/06107541.pdf [firstpage_image] =>[orig_patent_app_number] => 460744 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3824241 [patent_doc_number] => 05759765 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1998-06-02 [patent_title] => 'Human liver epithelial cell lines' [patent_app_type] => 1 [patent_app_number] => 8/458878 [patent_app_country] => US [patent_app_date] => 1995-06-02 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 7 [patent_figures_cnt] => 15 [patent_no_of_words] => 7856 [patent_no_of_claims] => 4 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 141 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/759/05759765.pdf [firstpage_image] =>[orig_patent_app_number] => 458878 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3724995 [patent_doc_number] => 05700690 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1997-12-23 [patent_title] => 'Compositions and methods for inhibiting fibrogenesis' [patent_app_type] => 1 [patent_app_number] => 8/452259 [patent_app_country] => US [patent_app_date] => 1995-05-26 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 2 [patent_no_of_words] => 6402 [patent_no_of_claims] => 6 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 43 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/700/05700690.pdf [firstpage_image] =>[orig_patent_app_number] => 452259 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4105931 [patent_doc_number] => 06022735 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2000-02-08 [patent_title] => 'Composition for introducing nucleic acid complexes into higher eucaryotic cells' [patent_app_type] => 1 [patent_app_number] => 8/449741 [patent_app_country] => US [patent_app_date] => 1995-05-25 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 65 [patent_figures_cnt] => 76 [patent_no_of_words] => 51873 [patent_no_of_claims] => 17 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 58 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/022/06022735.pdf [firstpage_image] =>[orig_patent_app_number] => 449741 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4137900 [patent_doc_number] => 06060270 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2000-05-09 [patent_title] => 'Methods and compositions for isolation and growth of kidney tubule stem cells, in vitro kidney tubulogenesis and ex vivo construction of renal tubules' [patent_app_type] => 1 [patent_app_number] => 8/449912 [patent_app_country] => US [patent_app_date] => 1995-05-25 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 7 [patent_figures_cnt] => 14 [patent_no_of_words] => 7151 [patent_no_of_claims] => 41 [patent_no_of_ind_claims] => 8 [patent_words_short_claim] => 68 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/060/06060270.pdf [firstpage_image] =>[orig_patent_app_number] => 449912 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4163575 [patent_doc_number] => 06139835 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2000-10-31 [patent_title] => 'Homologous recombination for allogeneic donor cells' [patent_app_type] => 1 [patent_app_number] => 8/443647 [patent_app_country] => US [patent_app_date] => 1995-05-18 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 12 [patent_figures_cnt] => 20 [patent_no_of_words] => 19695 [patent_no_of_claims] => 62 [patent_no_of_ind_claims] => 7 [patent_words_short_claim] => 90 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/139/06139835.pdf [firstpage_image] =>[orig_patent_app_number] => 443647 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3774585 [patent_doc_number] => 05849994 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1998-12-15 [patent_title] => 'Animal model for HIV-1 induced disease' [patent_app_type] => 1 [patent_app_number] => 8/442010 [patent_app_country] => US [patent_app_date] => 1995-05-16 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 4 [patent_no_of_words] => 5919 [patent_no_of_claims] => 11 [patent_no_of_ind_claims] => 7 [patent_words_short_claim] => 25 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/849/05849994.pdf [firstpage_image] =>[orig_patent_app_number] => 442010 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3927504 [patent_doc_number] => 05877159 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1999-03-02 [patent_title] => 'Method for introducing and expressing genes in animal cells and live invasive bacterial vectors for use in the same' [patent_app_type] => 1 [patent_app_number] => 8/433790 [patent_app_country] => US [patent_app_date] => 1995-05-03 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 6 [patent_figures_cnt] => 6 [patent_no_of_words] => 14396 [patent_no_of_claims] => 24 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 60 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/877/05877159.pdf [firstpage_image] =>[orig_patent_app_number] => 433790 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3774569 [patent_doc_number] => 05849993 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1998-12-15 [patent_title] => 'Transgenic mice as a model for metabolic bone diseases' [patent_app_type] => 1 [patent_app_number] => 8/428316 [patent_app_country] => US [patent_app_date] => 1995-04-25 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 6 [patent_figures_cnt] => 8 [patent_no_of_words] => 5666 [patent_no_of_claims] => 2 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 76 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/849/05849993.pdf [firstpage_image] =>[orig_patent_app_number] => 428316 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3900465 [patent_doc_number] => 05750825 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1998-05-12 [patent_title] => 'Mouse with defective endotheline-1 gene function' [patent_app_type] => 1 [patent_app_number] => 8/325181 [patent_app_country] => US [patent_app_date] => 1995-04-24 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 1 [patent_figures_cnt] => 2 [patent_no_of_words] => 3951 [patent_no_of_claims] => 5 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 81 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/750/05750825.pdf [firstpage_image] =>[orig_patent_app_number] => 325181 [rel_patent_id] =>[rel_patent_doc_number] =>)